AGP Picks
View all

Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on June 5, 2026

My TRT App releases free public bloodwork analyzer and peptide reference library
RL Health Launches New 2.0 ATA Hyperbaric Oxygen Chambers for Sports Recovery, Wellness Centers, and OEM Partners
One Water Systems Announces June Water Consultation Campaign and Filtration System Savings
Next Day Access Montana: New Franchise Location
Creative Biolabs' Webinar Explores New Mechanisms Driving Neurodegeneration
Baldivis Family Medical Centre Expands Regional Developmental Paediatric Services
Weight Loss Buddy Says Sustainable Habits May Matter More Than Perfect Health Optimization
Nashville Concierge Medicines Announces New Content on Suboxone Treatment in Nashville, TN
Caretaker Medical Receives CE Mark for VitalStream® Multimodal Wireless Patient Monitoring Platform
UltraSight™ to Participate in Mayo Clinic Innovation Summit Focused on the Future of Cardiovascular Care
Graphene Heating Films Market worth $1.51 billion by 2030, at 8.1%, says MarketsandMarkets™
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
Bay Club Completes 12th Washington State Acquisition, Continuing Build-Out of Greater Seattle Market
ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference
Global Norovirus Outbreaks, Ebola Emergency and Rising Disease Threats Highlight Growing Need for TOMI Environmental Solutions' SteraMist Technology
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™

Share this page:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.